Aura Biosciences Inc expected to post a loss of 45 cents a share - Earnings Preview

Aura Biosciences

05/08/2024 16:20

* Aura Biosciences Inc  AURA.OQ   AURA.O  is expected
to show no
change in quarterly revenue when it reports  results on August 7
(estimated) for the period ending June 30 2024
    * 
    * ​LSEG's mean analyst estimate for Aura Biosciences Inc is
for a
loss of 45 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Aura
Biosciences
Inc is $20.00​, above​ its last closing price of $9.24. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Mar. 31 2024  -0.48       -0.49      -0.40     Beat    17.7
 Dec. 31 2024  -0.44       -0.41      -0.56     Missed  -35.9
 Sep. 30 2023  -0.53       -0.52      -0.48     Beat    7.8​
 Jun. 30 2023  -0.49       -0.49      -0.48     Beat    2
 ​​Mar.        -0.53       -0.54      -0.46     Beat    14.9
 31 2023                                                
 Dec. 31 2022  -0.47       -0.52      -0.55     Missed  -5.3​
 Sep. 30 2022  -0.51       -0.51      -0.54     Missed  -6.7
 Jun. 30 2022  -0.46       -0.46      -0.46     Met     0.9
 This summary was machine generated August 5 at 15:20 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)